Insider trade

Director reported a gift or transfer of 30K ADMA shares

Traded Mar 17, 2026 · Filed Mar 18, 2026

ADMA Biologics, Inc.ADMA

30K
Shares

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 17, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 18, 2026

DirectorGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001140361-26-009900

Filed / recorded

Mar 18, 2026, 1:00 AM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ADMA BIOLOGICS, INC.

Issuer CIK

1368514

Ticker

ADMA

Reporting person

Lawrence P. Guiheen

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 17, 2026

Transaction code

G

Shares / units

30,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

105,520

Ownership form

Direct

Amendment

No

Footnotes from the filing

This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the "2019 Guiheen Irrevocable Trust"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person.